Abstract Aim The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management
of Patients With Chronic Coronary Disease” provides an update to and consolidates new …

Controlling hypertension (HTN) remains a challenge, as it is affected by various factors in
different settings. This study aimed to describe the disparities in the prevalence and barriers …

Background This study aims to identify interventions used to reduce medication regimen
complexity and to assess their impact on medication adherence and clinical outcomes …

Affective disorders are a common psychological impairment. A major problem with respect to
treatment is medication non-adherence. eHealth interventions are already widely used in …

Medication non‐adherence is currently estimated to have caused at least 100 000
preventable deaths and over $100 billion in preventable medical costs. Adherence is …

The perspectives of hypertensive patients on the state of hypertension control during the
ongoing pandemic restrictions have not been extensively studied in Malaysia. Therefore …

Aims This study determined the impact of a pharmacist‐led educational intervention on the
health outcomes of hypertensive patients in community pharmacies. Methods A 2‐arm …

Objectives Medication adherence in cardiovascular disease (CVD) is reported to be
suboptimal. Therefore, an intervention to tackle non-adherence is important. Pharmacists' …

The NHS Long Term Plan emphasises the vital role of prevention in the NHS of the future. 1
Optimising patients' medical management of chronic disease is an opportunity for primary …

Background: Adherence to a medication regimen is defined as taking the medication as
directed by the prescriber. Adherence is critical to achieve the desired therapeutic outcomes …